Clinical Trial Update: Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer [NA]

View source ↗

Summary

A Mayo Clinic-led clinical trial evaluated Acitretin for preventing skin cancer in individuals at high risk, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• Acitretin (Acitretin)

Snippet

Sponsor: Mayo Clinic | Conditions: Non-melanomatous Skin Cancer | NA | Status: COMPLETED